nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—Progesterone—uterine cancer	0.149	0.177	CbGbCtD
Isoniazid—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.111	0.132	CbGbCtD
Isoniazid—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0774	0.092	CbGbCtD
Isoniazid—CYP2C8—Progesterone—uterine cancer	0.0735	0.0873	CbGbCtD
Isoniazid—CYP2C19—Progesterone—uterine cancer	0.0616	0.0733	CbGbCtD
Isoniazid—CYP1A2—Progesterone—uterine cancer	0.0569	0.0676	CbGbCtD
Isoniazid—CYP2C9—Progesterone—uterine cancer	0.0512	0.0609	CbGbCtD
Isoniazid—CYP2D6—Progesterone—uterine cancer	0.0469	0.0557	CbGbCtD
Isoniazid—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.045	0.0535	CbGbCtD
Isoniazid—CYP2E1—Etoposide—uterine cancer	0.044	0.0523	CbGbCtD
Isoniazid—CYP2C8—Etoposide—uterine cancer	0.0329	0.0391	CbGbCtD
Isoniazid—CYP3A4—Progesterone—uterine cancer	0.0298	0.0354	CbGbCtD
Isoniazid—CYP1A2—Etoposide—uterine cancer	0.0254	0.0303	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—uterine cancer	0.0143	0.017	CbGbCtD
Isoniazid—CYP3A4—Etoposide—uterine cancer	0.0133	0.0159	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—uterine cancer	0.00909	0.0108	CbGbCtD
Isoniazid—Optic neuritis—Progesterone—uterine cancer	0.00416	0.0309	CcSEcCtD
Isoniazid—Optic neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00377	0.028	CcSEcCtD
Isoniazid—Neuritis—Progesterone—uterine cancer	0.00343	0.0255	CcSEcCtD
Isoniazid—Neurotoxicity—Etoposide—uterine cancer	0.00338	0.0251	CcSEcCtD
Isoniazid—Metabolic acidosis—Etoposide—uterine cancer	0.00331	0.0246	CcSEcCtD
Isoniazid—Memory impairment—Progesterone—uterine cancer	0.00326	0.0242	CcSEcCtD
Isoniazid—Neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00311	0.0231	CcSEcCtD
Isoniazid—Eruption—Dactinomycin—uterine cancer	0.00294	0.0218	CcSEcCtD
Isoniazid—Hepatocellular injury—Progesterone—uterine cancer	0.00256	0.019	CcSEcCtD
Isoniazid—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.0172	CcSEcCtD
Isoniazid—Lymphadenopathy—Progesterone—uterine cancer	0.00218	0.0162	CcSEcCtD
Isoniazid—Optic neuritis—Etoposide—uterine cancer	0.00213	0.0158	CcSEcCtD
Isoniazid—Hepatic function abnormal—Progesterone—uterine cancer	0.00213	0.0158	CcSEcCtD
Isoniazid—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.0144	CcSEcCtD
Isoniazid—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.0143	CcSEcCtD
Isoniazid—Neurotoxicity—Epirubicin—uterine cancer	0.00189	0.0141	CcSEcCtD
Isoniazid—Neurotoxicity—Doxorubicin—uterine cancer	0.00175	0.013	CcSEcCtD
Isoniazid—Aplastic anaemia—Dactinomycin—uterine cancer	0.0017	0.0126	CcSEcCtD
Isoniazid—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.0122	CcSEcCtD
Isoniazid—Hyperglycaemia—Progesterone—uterine cancer	0.00145	0.0108	CcSEcCtD
Isoniazid—Neuropathy peripheral—Progesterone—uterine cancer	0.0014	0.0104	CcSEcCtD
Isoniazid—Jaundice—Progesterone—uterine cancer	0.0014	0.0104	CcSEcCtD
Isoniazid—Body temperature increased—Carboplatin—uterine cancer	0.00137	0.0102	CcSEcCtD
Isoniazid—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00975	CcSEcCtD
Isoniazid—Hepatitis—Progesterone—uterine cancer	0.00129	0.00954	CcSEcCtD
Isoniazid—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00944	CcSEcCtD
Isoniazid—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00939	CcSEcCtD
Isoniazid—Eruption—Epirubicin—uterine cancer	0.00119	0.00886	CcSEcCtD
Isoniazid—Optic neuritis—Epirubicin—uterine cancer	0.00119	0.00886	CcSEcCtD
Isoniazid—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00865	CcSEcCtD
Isoniazid—Optic neuritis—Doxorubicin—uterine cancer	0.0011	0.0082	CcSEcCtD
Isoniazid—Eruption—Doxorubicin—uterine cancer	0.0011	0.0082	CcSEcCtD
Isoniazid—Ill-defined disorder—Progesterone—uterine cancer	0.00104	0.00771	CcSEcCtD
Isoniazid—Malaise—Progesterone—uterine cancer	0.00101	0.00749	CcSEcCtD
Isoniazid—Neuritis—Epirubicin—uterine cancer	0.000984	0.0073	CcSEcCtD
Isoniazid—Convulsion—Progesterone—uterine cancer	0.00097	0.0072	CcSEcCtD
Isoniazid—Agranulocytosis—Dactinomycin—uterine cancer	0.000945	0.00701	CcSEcCtD
Isoniazid—Discomfort—Progesterone—uterine cancer	0.000942	0.00699	CcSEcCtD
Isoniazid—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000941	0.00699	CcSEcCtD
Isoniazid—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000915	0.00679	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—uterine cancer	0.00091	0.00675	CcSEcCtD
Isoniazid—Hepatitis—Dactinomycin—uterine cancer	0.000909	0.00675	CcSEcCtD
Isoniazid—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000879	0.00652	CcSEcCtD
Isoniazid—Liver injury—Epirubicin—uterine cancer	0.000873	0.00648	CcSEcCtD
Isoniazid—Anorexia—Progesterone—uterine cancer	0.000871	0.00646	CcSEcCtD
Isoniazid—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.00633	CcSEcCtD
Isoniazid—Paraesthesia—Progesterone—uterine cancer	0.00082	0.00609	CcSEcCtD
Isoniazid—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00602	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.000808	0.00599	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—uterine cancer	0.000808	0.00599	CcSEcCtD
Isoniazid—Dyspepsia—Progesterone—uterine cancer	0.000804	0.00597	CcSEcCtD
Isoniazid—Decreased appetite—Progesterone—uterine cancer	0.000794	0.00589	CcSEcCtD
Isoniazid—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000789	0.00586	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Progesterone—uterine cancer	0.000789	0.00585	CcSEcCtD
Isoniazid—Fatigue—Progesterone—uterine cancer	0.000788	0.00585	CcSEcCtD
Isoniazid—Feeling abnormal—Progesterone—uterine cancer	0.000753	0.00559	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.000747	0.00555	CcSEcCtD
Isoniazid—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000743	0.00552	CcSEcCtD
Isoniazid—Hepatocellular injury—Epirubicin—uterine cancer	0.000734	0.00545	CcSEcCtD
Isoniazid—Ill-defined disorder—Dactinomycin—uterine cancer	0.000734	0.00545	CcSEcCtD
Isoniazid—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000729	0.00541	CcSEcCtD
Isoniazid—Body temperature increased—Progesterone—uterine cancer	0.000722	0.00536	CcSEcCtD
Isoniazid—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.00534	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—uterine cancer	0.000718	0.00533	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000715	0.0053	CcSEcCtD
Isoniazid—Jaundice—Etoposide—uterine cancer	0.000714	0.0053	CcSEcCtD
Isoniazid—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000714	0.0053	CcSEcCtD
Isoniazid—Malaise—Dactinomycin—uterine cancer	0.000714	0.0053	CcSEcCtD
Isoniazid—Aplastic anaemia—Epirubicin—uterine cancer	0.000689	0.00512	CcSEcCtD
Isoniazid—Agranulocytosis—Etoposide—uterine cancer	0.000684	0.00508	CcSEcCtD
Isoniazid—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000682	0.00506	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—uterine cancer	0.00068	0.00504	CcSEcCtD
Isoniazid—Hypersensitivity—Progesterone—uterine cancer	0.000673	0.005	CcSEcCtD
Isoniazid—Discomfort—Dactinomycin—uterine cancer	0.000666	0.00494	CcSEcCtD
Isoniazid—Asthenia—Progesterone—uterine cancer	0.000656	0.00487	CcSEcCtD
Isoniazid—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000655	0.00486	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—uterine cancer	0.000638	0.00473	CcSEcCtD
Isoniazid—Thrombocytopenia—Dactinomycin—uterine cancer	0.000632	0.00469	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—uterine cancer	0.000625	0.00464	CcSEcCtD
Isoniazid—Anorexia—Dactinomycin—uterine cancer	0.000616	0.00457	CcSEcCtD
Isoniazid—Diabetes mellitus—Epirubicin—uterine cancer	0.000613	0.00455	CcSEcCtD
Isoniazid—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00061	0.00453	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—uterine cancer	0.00061	0.00453	CcSEcCtD
Isoniazid—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000594	0.00441	CcSEcCtD
Isoniazid—Vomiting—Progesterone—uterine cancer	0.000581	0.00431	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—uterine cancer	0.000578	0.00429	CcSEcCtD
Isoniazid—Rash—Progesterone—uterine cancer	0.000576	0.00428	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—uterine cancer	0.000567	0.00421	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000564	0.00419	CcSEcCtD
Isoniazid—Decreased appetite—Dactinomycin—uterine cancer	0.000561	0.00417	CcSEcCtD
Isoniazid—Fatigue—Dactinomycin—uterine cancer	0.000557	0.00413	CcSEcCtD
Isoniazid—Nausea—Progesterone—uterine cancer	0.000543	0.00403	CcSEcCtD
Isoniazid—Feeling abnormal—Dactinomycin—uterine cancer	0.000532	0.00395	CcSEcCtD
Isoniazid—Ill-defined disorder—Etoposide—uterine cancer	0.000531	0.00394	CcSEcCtD
Isoniazid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000526	0.00391	CcSEcCtD
Isoniazid—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000522	0.00387	CcSEcCtD
Isoniazid—Malaise—Etoposide—uterine cancer	0.000516	0.00383	CcSEcCtD
Isoniazid—Body temperature increased—Dactinomycin—uterine cancer	0.000511	0.00379	CcSEcCtD
Isoniazid—Convulsion—Etoposide—uterine cancer	0.000496	0.00368	CcSEcCtD
Isoniazid—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000492	0.00365	CcSEcCtD
Isoniazid—Discomfort—Etoposide—uterine cancer	0.000482	0.00358	CcSEcCtD
Isoniazid—Hypersensitivity—Dactinomycin—uterine cancer	0.000476	0.00353	CcSEcCtD
Isoniazid—Asthenia—Dactinomycin—uterine cancer	0.000463	0.00344	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—uterine cancer	0.000458	0.0034	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—uterine cancer	0.000456	0.00339	CcSEcCtD
Isoniazid—Anorexia—Etoposide—uterine cancer	0.000446	0.00331	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—uterine cancer	0.000422	0.00313	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—uterine cancer	0.00042	0.00311	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—uterine cancer	0.000416	0.00308	CcSEcCtD
Isoniazid—Vomiting—Dactinomycin—uterine cancer	0.000411	0.00305	CcSEcCtD
Isoniazid—Rash—Dactinomycin—uterine cancer	0.000407	0.00302	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—uterine cancer	0.000406	0.00302	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—uterine cancer	0.000404	0.00299	CcSEcCtD
Isoniazid—Fatigue—Etoposide—uterine cancer	0.000403	0.00299	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—uterine cancer	0.000403	0.00299	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—uterine cancer	0.0004	0.00297	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—uterine cancer	0.000385	0.00286	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—uterine cancer	0.000385	0.00285	CcSEcCtD
Isoniazid—Nausea—Dactinomycin—uterine cancer	0.000384	0.00285	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—uterine cancer	0.000383	0.00285	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000373	0.00277	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—uterine cancer	0.000371	0.00275	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—uterine cancer	0.000369	0.00274	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—uterine cancer	0.000369	0.00274	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—uterine cancer	0.000355	0.00263	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—uterine cancer	0.000344	0.00256	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—uterine cancer	0.000341	0.00253	CcSEcCtD
Isoniazid—Asthenia—Etoposide—uterine cancer	0.000335	0.00249	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—uterine cancer	0.000298	0.00221	CcSEcCtD
Isoniazid—Vomiting—Etoposide—uterine cancer	0.000297	0.00221	CcSEcCtD
Isoniazid—Rash—Etoposide—uterine cancer	0.000295	0.00219	CcSEcCtD
Isoniazid—Malaise—Epirubicin—uterine cancer	0.000289	0.00215	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—uterine cancer	0.000278	0.00206	CcSEcCtD
Isoniazid—Nausea—Etoposide—uterine cancer	0.000278	0.00206	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—uterine cancer	0.000276	0.00205	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—uterine cancer	0.00027	0.002	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—uterine cancer	0.000268	0.00199	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—uterine cancer	0.000257	0.00191	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—uterine cancer	0.000257	0.0019	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—uterine cancer	0.00025	0.00185	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—uterine cancer	0.00025	0.00185	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—uterine cancer	0.000237	0.00176	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—uterine cancer	0.000235	0.00175	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—uterine cancer	0.000231	0.00171	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—uterine cancer	0.000231	0.00171	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—uterine cancer	0.000228	0.00169	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000226	0.00168	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—uterine cancer	0.000226	0.00168	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—uterine cancer	0.000218	0.00162	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—uterine cancer	0.000216	0.0016	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—uterine cancer	0.000213	0.00158	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—uterine cancer	0.000211	0.00156	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000209	0.00155	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—uterine cancer	0.000209	0.00155	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—uterine cancer	0.000207	0.00154	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—uterine cancer	0.0002	0.00148	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—uterine cancer	0.000193	0.00143	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—uterine cancer	0.000192	0.00142	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—uterine cancer	0.000188	0.0014	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—uterine cancer	0.000179	0.00133	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—uterine cancer	0.000174	0.00129	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—uterine cancer	0.000167	0.00124	CcSEcCtD
Isoniazid—Rash—Epirubicin—uterine cancer	0.000165	0.00123	CcSEcCtD
Isoniazid—Nausea—Epirubicin—uterine cancer	0.000156	0.00115	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—uterine cancer	0.000154	0.00114	CcSEcCtD
Isoniazid—Rash—Doxorubicin—uterine cancer	0.000153	0.00113	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—uterine cancer	0.000144	0.00107	CcSEcCtD
Isoniazid—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	8.41e-05	0.00348	CbGpPWpGaD
Isoniazid—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.36e-05	0.00346	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	8.01e-05	0.00332	CbGpPWpGaD
Isoniazid—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	7.99e-05	0.00331	CbGpPWpGaD
Isoniazid—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	7.99e-05	0.00331	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	7.88e-05	0.00326	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—RRM2—uterine cancer	7.57e-05	0.00313	CbGpPWpGaD
Isoniazid—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	7.49e-05	0.0031	CbGpPWpGaD
Isoniazid—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	7.42e-05	0.00307	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	7.37e-05	0.00305	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—DCN—uterine cancer	7.35e-05	0.00304	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	7.31e-05	0.00303	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	7.3e-05	0.00302	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	7.28e-05	0.00301	CbGpPWpGaD
Isoniazid—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.14e-05	0.00296	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	7.06e-05	0.00292	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	7.03e-05	0.00291	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—CYP11A1—uterine cancer	6.92e-05	0.00287	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	6.91e-05	0.00286	CbGpPWpGaD
Isoniazid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.8e-05	0.00282	CbGpPWpGaD
Isoniazid—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	6.71e-05	0.00278	CbGpPWpGaD
Isoniazid—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	6.62e-05	0.00274	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.58e-05	0.00273	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	6.56e-05	0.00272	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—AKR1C3—uterine cancer	6.54e-05	0.00271	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	6.53e-05	0.0027	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	6.47e-05	0.00268	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	6.41e-05	0.00265	CbGpPWpGaD
Isoniazid—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	6.31e-05	0.00261	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	6.24e-05	0.00258	CbGpPWpGaD
Isoniazid—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	6.23e-05	0.00258	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	6.17e-05	0.00255	CbGpPWpGaD
Isoniazid—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	6.09e-05	0.00252	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	6.04e-05	0.0025	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	6e-05	0.00249	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	5.95e-05	0.00246	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.88e-05	0.00243	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	5.67e-05	0.00235	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	5.62e-05	0.00233	CbGpPWpGaD
Isoniazid—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.51e-05	0.00228	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	5.48e-05	0.00227	CbGpPWpGaD
Isoniazid—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	5.46e-05	0.00226	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	5.38e-05	0.00223	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.36e-05	0.00222	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	5.16e-05	0.00214	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—STK11—uterine cancer	5.09e-05	0.00211	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—CYP19A1—uterine cancer	5.09e-05	0.00211	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	5.09e-05	0.00211	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	4.95e-05	0.00205	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	4.95e-05	0.00205	CbGpPWpGaD
Isoniazid—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	4.87e-05	0.00202	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	4.82e-05	0.00199	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	4.8e-05	0.00199	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	4.8e-05	0.00199	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.76e-05	0.00197	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.76e-05	0.00197	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.58e-05	0.0019	CbGpPWpGaD
Isoniazid—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	4.48e-05	0.00185	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	4.44e-05	0.00184	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	4.42e-05	0.00183	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	4.38e-05	0.00181	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	4.35e-05	0.0018	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	4.35e-05	0.0018	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—SRD5A2—uterine cancer	4.29e-05	0.00178	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NDUFB11—uterine cancer	4.29e-05	0.00178	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.25e-05	0.00176	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.25e-05	0.00176	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	4.23e-05	0.00175	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	4.12e-05	0.0017	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	4.06e-05	0.00168	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.98e-05	0.00165	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.93e-05	0.00163	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.87e-05	0.0016	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.87e-05	0.0016	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—MTHFR—uterine cancer	3.83e-05	0.00158	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	3.79e-05	0.00157	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	3.74e-05	0.00155	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.71e-05	0.00153	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	3.5e-05	0.00145	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.49e-05	0.00145	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NDUFB11—uterine cancer	3.39e-05	0.0014	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—SRD5A2—uterine cancer	3.39e-05	0.0014	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.31e-05	0.00137	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.31e-05	0.00137	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.12e-05	0.00129	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—STAR—uterine cancer	3.1e-05	0.00128	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKR1B1—uterine cancer	3.1e-05	0.00128	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.97e-05	0.00123	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.93e-05	0.00121	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.93e-05	0.00121	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.93e-05	0.00121	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.89e-05	0.0012	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.85e-05	0.00118	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.84e-05	0.00118	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.69e-05	0.00111	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.62e-05	0.00108	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.62e-05	0.00108	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.54e-05	0.00105	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKR1B1—uterine cancer	2.45e-05	0.00102	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—STAR—uterine cancer	2.45e-05	0.00102	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—POLD1—uterine cancer	2.43e-05	0.00101	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.43e-05	0.00101	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.41e-05	0.000996	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.41e-05	0.000996	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.4e-05	0.000994	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.39e-05	0.000988	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.39e-05	0.000988	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.32e-05	0.00096	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKR1C1—uterine cancer	2.28e-05	0.000943	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.19e-05	0.000906	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PTEN—uterine cancer	2.13e-05	0.000881	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—STAR—uterine cancer	2.12e-05	0.000878	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.12e-05	0.000878	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.1e-05	0.000867	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.04e-05	0.000844	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.04e-05	0.000844	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—EP300—uterine cancer	2.03e-05	0.00084	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—RRM2—uterine cancer	2.03e-05	0.00084	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.98e-05	0.00082	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—DCN—uterine cancer	1.97e-05	0.000816	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—POLD1—uterine cancer	1.92e-05	0.000797	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.89e-05	0.000783	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—STAR—uterine cancer	1.89e-05	0.000783	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.87e-05	0.000774	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.87e-05	0.000774	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.86e-05	0.000769	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.8e-05	0.000745	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.75e-05	0.000726	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.74e-05	0.00072	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—STAR—uterine cancer	1.74e-05	0.00072	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.73e-05	0.000714	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—STAR—uterine cancer	1.73e-05	0.000714	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.71e-05	0.000706	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—POLD1—uterine cancer	1.66e-05	0.000689	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—RRM2—uterine cancer	1.6e-05	0.000664	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.57e-05	0.000651	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.57e-05	0.000651	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—DCN—uterine cancer	1.56e-05	0.000645	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.56e-05	0.000644	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PIK3CA—uterine cancer	1.5e-05	0.000622	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—POLD1—uterine cancer	1.48e-05	0.000615	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—STAR—uterine cancer	1.47e-05	0.00061	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.47e-05	0.00061	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.47e-05	0.000607	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.46e-05	0.000603	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.39e-05	0.000575	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—RRM2—uterine cancer	1.39e-05	0.000574	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.39e-05	0.000574	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—STK11—uterine cancer	1.37e-05	0.000566	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.37e-05	0.000566	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—POLD1—uterine cancer	1.37e-05	0.000565	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—POLD1—uterine cancer	1.35e-05	0.00056	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—DCN—uterine cancer	1.35e-05	0.000557	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.28e-05	0.000529	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.27e-05	0.000525	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.27e-05	0.000524	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—RRM2—uterine cancer	1.24e-05	0.000512	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—AKT1—uterine cancer	1.23e-05	0.000508	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—DCN—uterine cancer	1.2e-05	0.000497	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.2e-05	0.000496	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—POLD1—uterine cancer	1.16e-05	0.000479	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—RRM2—uterine cancer	1.14e-05	0.000471	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.14e-05	0.000471	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—STAR—uterine cancer	1.14e-05	0.000471	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000469	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—RRM2—uterine cancer	1.13e-05	0.000467	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—DCN—uterine cancer	1.11e-05	0.000458	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—DCN—uterine cancer	1.1e-05	0.000454	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.08e-05	0.000448	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—STK11—uterine cancer	1.08e-05	0.000447	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.08e-05	0.000447	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.07e-05	0.000443	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.04e-05	0.000431	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000427	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—MTHFR—uterine cancer	1.03e-05	0.000425	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKR1C3—uterine cancer	9.83e-06	0.000407	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKR1C3—uterine cancer	9.75e-06	0.000404	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—RRM2—uterine cancer	9.64e-06	0.000399	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—DCN—uterine cancer	9.36e-06	0.000388	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP19A1—uterine cancer	9.33e-06	0.000386	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—STK11—uterine cancer	9.33e-06	0.000386	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—POLD1—uterine cancer	8.93e-06	0.00037	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP11A1—uterine cancer	8.82e-06	0.000365	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.76e-06	0.000363	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.35e-06	0.000346	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKR1C1—uterine cancer	8.35e-06	0.000346	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKR1C3—uterine cancer	8.33e-06	0.000345	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—STK11—uterine cancer	8.33e-06	0.000345	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP19A1—uterine cancer	8.33e-06	0.000345	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—MTHFR—uterine cancer	8.11e-06	0.000336	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.82e-06	0.000324	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—STK11—uterine cancer	7.66e-06	0.000317	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP19A1—uterine cancer	7.66e-06	0.000317	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—STK11—uterine cancer	7.59e-06	0.000314	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP19A1—uterine cancer	7.59e-06	0.000314	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.46e-06	0.000309	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—RRM2—uterine cancer	7.44e-06	0.000308	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—DCN—uterine cancer	7.23e-06	0.000299	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.13e-06	0.000295	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—MTHFR—uterine cancer	7.01e-06	0.00029	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.81e-06	0.000282	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.8e-06	0.000281	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—STK11—uterine cancer	6.49e-06	0.000269	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP19A1—uterine cancer	6.49e-06	0.000269	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.43e-06	0.000266	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—MTHFR—uterine cancer	6.26e-06	0.000259	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.18e-06	0.000256	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.09e-06	0.000252	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.81e-06	0.00024	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—MTHFR—uterine cancer	5.76e-06	0.000238	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTEN—uterine cancer	5.71e-06	0.000236	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—MTHFR—uterine cancer	5.71e-06	0.000236	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.52e-06	0.000228	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—EP300—uterine cancer	5.45e-06	0.000225	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.03e-06	0.000208	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.01e-06	0.000207	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—STK11—uterine cancer	5.01e-06	0.000207	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—MTHFR—uterine cancer	4.88e-06	0.000202	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTEN—uterine cancer	4.51e-06	0.000187	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—EP300—uterine cancer	4.3e-06	0.000178	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.3e-06	0.000178	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CA—uterine cancer	4.03e-06	0.000167	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTEN—uterine cancer	3.9e-06	0.000161	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MTHFR—uterine cancer	3.76e-06	0.000156	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—EP300—uterine cancer	3.72e-06	0.000154	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTEN—uterine cancer	3.48e-06	0.000144	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—EP300—uterine cancer	3.32e-06	0.000137	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKT1—uterine cancer	3.29e-06	0.000136	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTEN—uterine cancer	3.2e-06	0.000133	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.18e-06	0.000132	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTEN—uterine cancer	3.17e-06	0.000131	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—EP300—uterine cancer	3.05e-06	0.000126	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—EP300—uterine cancer	3.03e-06	0.000125	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.75e-06	0.000114	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTEN—uterine cancer	2.71e-06	0.000112	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKT1—uterine cancer	2.6e-06	0.000108	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—EP300—uterine cancer	2.59e-06	0.000107	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.46e-06	0.000102	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.26e-06	9.35e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKT1—uterine cancer	2.25e-06	9.31e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.24e-06	9.27e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTEN—uterine cancer	2.09e-06	8.67e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKT1—uterine cancer	2.01e-06	8.31e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—EP300—uterine cancer	2e-06	8.27e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.91e-06	7.92e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKT1—uterine cancer	1.85e-06	7.64e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKT1—uterine cancer	1.83e-06	7.57e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKT1—uterine cancer	1.56e-06	6.47e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.48e-06	6.11e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKT1—uterine cancer	1.21e-06	5e-05	CbGpPWpGaD
